All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • SYT-510Phase 21 trial

    Synendos Therapeutics AG · Generalized Anxiety Disorder

  • T1695Phase 21 trial

    Laboratoires Thea · Moderate to Severe Vernal Keratoconjunctivitis

  • Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation

  • TagmokitugPhase 21 trial

    Coherus Oncology, Inc. · Solid Tumor

  • TAK-007Phase 21 trial

    Takeda · Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

  • TAK-101Phase 21 trial

    Takeda · Celiac Disease

  • TAK-188Phase 21 trial

    Takeda · Advanced or Metastatic Solid Tumors

  • TAK-242Phase 21 trial

    Yaqrit Ltd · Acute-On-Chronic Liver Failure, Alcoholic Hepatitis, Liver Cirrhosis, Alcoholic

  • TAK-341MEDI1341Phase 21 trial

    Takeda · Multiple System Atrophy

  • TAK-411Hypersialylated Immune Globulin GPhase 21 trial

    Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • TAK-505Phase 21 trial

    Takeda · Malignant Solid Tumors

  • TAR-0520Phase 21 trial

    Tarian Pharma · Hand and Foot Syndrome

  • TAS0953HM06Phase 21 trial

    Taiho Pharmaceutical Co., Ltd. · RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors

  • TAVO101Phase 21 trial

    Tavotek Biotherapeutics · Atopic Dermatitis

  • TavoceptLP-300, BNP7787Phase 21 trial

    Lantern Pharma Inc. · Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

  • TB-500Phase 21 trial

    Hudson Biotech · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction

  • TB006Phase 21 trial

    TrueBinding, Inc. · Parkinson's Disease (PD)

  • TB511Phase 21 trial

    Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer

  • TBI-1501Phase 21 trial

    Takara Bio Inc. · Lymphoblastic Leukemia, Acute Adult

  • TBO-309Phase 21 trial

    ThromBio Pty. Ltd. · Ischemic Stroke, Tandem Occlusion

  • TBS-2025trovostobartPhase 21 trial

    TuHURA Biosciences, Inc. · Acute Myeloid Leukemia

  • TC011Phase 21 trial

    TICAROS Co., Ltd. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)

  • TCMCB07Phase 21 trial

    Endevica Bio · Cancer Weight Loss

  • TCP-25Phase 21 trial

    Xinnate AB · Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa

  • TD001Phase 21 trial

    T.O.A.D. Oncology SA · Metastatic Castration-Resistant Prostatic Cancer

  • TenalisibRP6530Phase 21 trial

    Rhizen Pharmaceuticals SA · Triple Negative Breast Cancer (TNBC)

  • TER-2013Phase 21 trial

    Terremoto Biosciences Inc. · Breast Cancer, Endometrial Cancer, Ovarian Cancer

  • TERN-601Phase 21 trial

    Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) · Overweight or Obesity

  • TG4001Phase 21 trial

    Transgene · HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma

  • TG4050Phase 21 trial

    Transgene · Squamous Cell Carcinoma of Head and Neck

  • TGD001Phase 21 trial

    TargED Biopharmaceuticals B.V. · Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia

  • TGM-312-SC01Phase 21 trial

    Tangram Therapeutics Plc · Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis

  • TGRX-814Phase 21 trial

    Shenzhen TargetRx Co., Ltd. · Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia

  • TGX-007Phase 21 trial

    Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma

  • TH9619Phase 21 trial

    One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck

  • THDBH120Phase 21 trial

    Tonghua Dongbao Pharmaceutical Co.,Ltd · Overweight or Obese

  • TILT-123Ad5, 3-E2F-d24-hTNFa-IRES-hIL2Phase 21 trial

    TILT Biotherapeutics Ltd. · Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Platinum-Resistant Fallopian Tube Carcinoma

  • TISA-818-InjPhase 21 trial

    EnliTISA (Shanghai) Pharmaceutical Co., Ltd. · Acute Respiratory Distress Syndrome (ARDS)

  • TJ004309Phase 21 trial

    TJ Biopharma Co., Ltd. · Advanced Solid Tumor

  • TJ102Phase 21 trial

    Phrontline Biopharma · Ovarian Cancer

  • TJO-087Phase 21 trial

    Taejoon Pharmaceutical Co., Ltd. · Dry Eye Syndrome (DES)

  • TK216Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Sarcoma, Ewing

  • TL-895Phase 21 trial

    Telios Pharma, Inc. · Myelofibrosis, Primary Myelofibrosis, Post-PV MF

  • TL117Phase 21 trial

    Suzhou Junde Biotechnology Co., Ltd · Head and Neck Squamous Cell Carcinoma

  • TL118Phase 21 trial

    Teligene US · Solid Tumor

  • TL938Phase 21 trial

    Teligene US · Colorectal Cancer Metastatic, Advanced Colorectal Cancer

  • TNG260Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer

  • TNG456Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant

  • TominersenRO7234292, RG6042Phase 21 trial

    Roche (Genentech) · Huntington Disease

  • TPX-100Phase 21 trial

    OrthoTrophix, Inc · Osteoarthritis (OA) of the Knee

NewerPage 71 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.